The Cigna Group (CI) Revenue — Quarter Ended Mar 31, 2024
Revenue increased compared with the prior quarter and rose sharply versus the same quarter last year. The growth was driven by higher pharmacy revenues and premiums.
Key takeaway
Quarter ended Mar 31, 2024 · FY2024 Q1
Revenue increased compared with the prior quarter and rose sharply versus the same quarter last year. The growth was driven by higher pharmacy revenues and premiums.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$57.3B
Revenue reported for this quarter.
Quarter-over-quarter
+12.0%
Change from the immediately preceding quarter.
Year-over-year
+23.1%
Change from the comparable year-ago quarter.
Trailing four quarters
$206B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Jun 30, 2023 | $48.6B | +6.8% |
| Sep 30, 2023 | $49B | +8.3% |
| Dec 31, 2023 | $51.1B | +11.7% |
| Mar 31, 2024 | $57.3B | +23.1% |
Revenue performance
Total revenues for the quarter were higher than the immediately preceding quarter, reflecting continued expansion in the company's pharmacy and health services segments.
Quarterly comparison
Compared with the same quarter one year earlier, total revenues increased significantly, with pharmacy revenues and premiums both contributing to the gain.
What to watch
The company reported a net loss for the quarter, primarily due to realized investment losses, which may warrant attention in future periods.